UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000036287
Receipt number R000041331
Scientific Title Clinical Application of a novel Robot for separate body weight support treadmill training in poststroke gait disorder
Date of disclosure of the study information 2019/03/26
Last modified on 2023/10/01 17:22:11

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Clinical Application of a novel Robot for separate body weight support treadmill training in poststroke gait disorder

Acronym

Clinical Application of a novel Robot for separate body weight support treadmill training in poststroke gait disorder

Scientific Title

Clinical Application of a novel Robot for separate body weight support treadmill training in poststroke gait disorder

Scientific Title:Acronym

Clinical Application of a novel Robot for separate body weight support treadmill training in poststroke gait disorder

Region

Japan


Condition

Condition

Stroke

Classification by specialty

Neurology Rehabilitation medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Treadmill training with or without partial body weight supported (BWS) is a task-oriented training for gait recovery. Previous studies suggest that body weight supported treadmill training (BWSTT) is effective to improve post-stroke gait disorder. Since conventional BWS continuously support both sides of the body, temporal support for each leg according to the gait cycle cannot be optimized. We developed a novel BWS robot to support the right and left body separately using pneumatic artificial muscles. We assessed whether the robot could modulate gait pattern in post-stroke hemiplegia.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

Symmetry indexes of stance phase and swing phase duration of gait.

Key secondary outcomes

Fugl-Meyer Assessment, 10-Meter walk test, Timed-Up and go test, Berg Balance Scale, kinematic data from the BWS robot and motion analysis system


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Hemiparetic patients with stroke

Key exclusion criteria

Dementia(MMSE<24), severe aphasia, severe heart, respiratory, and/or orthopedic diseases, pain

Target sample size

50


Research contact person

Name of lead principal investigator

1st name Ichiro
Middle name
Last name Miyai

Organization

Morinomiya Hospital

Division name

Neurorehabilitation Research Institute

Zip code

536-0025

Address

2-1-88 Morinomiya, Joto-ku, Osaka City, Osaka, Japan

TEL

8-6-6969-0111

Email

miyai@omichikai.or.jp


Public contact

Name of contact person

1st name Misako
Middle name
Last name Miyata

Organization

Morinomiya Hospital

Division name

Officer

Zip code

536-0025

Address

2-1-88 Morinomiya, Joto-ku, Osaka City, Osaka, Japan

TEL

8-6-6969-0111

Homepage URL


Email

miyata@omichikai.or.jp


Sponsor or person

Institute

ATR Computational Neuroscience Labs, Dept. of Brain Robot Interface

Institute

Department

Personal name



Funding Source

Organization

NICT: National Institute of Information and Communications Technology

Organization

Division

Category of Funding Organization

Government offices of other countries

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Omichi-kai Social Medical Corporation Ethics Committee

Address

2-1-88 Morinomiya, Joto-ku, Osaka City, Osaka, Japan

Tel

8-6-6969-0111

Email

miyata@omichikai.or.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

森之宮病院(大阪府)


Other administrative information

Date of disclosure of the study information

2019 Year 03 Month 26 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2019 Year 11 Month 30 Day

Date of IRB

2019 Year 11 Month 28 Day

Anticipated trial start date

2019 Year 11 Month 30 Day

Last follow-up date

2023 Year 03 Month 31 Day

Date of closure to data entry

2023 Year 12 Month 31 Day

Date trial data considered complete

2023 Year 12 Month 31 Day

Date analysis concluded

2024 Year 03 Month 31 Day


Other

Other related information

None


Management information

Registered date

2019 Year 03 Month 25 Day

Last modified on

2023 Year 10 Month 01 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000041331


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name